Chronic hepatitis F8: Liver or gallbladder prolems with lower back pain, blurred vision, dry eye or prostate problem.

1. Chronic hepatitis: 32 chronic virus hepatitis patients in two reports took F8 for three months and all were improved (93.8 percent) but two.

2. Chronic retinitis: 169 chronic retinitis patients took F8 from 30 to 118 days and 47 were cured (27.81 percent), 25 significantly improved (14.79 percent), 70 improved (41.42 percent) and 27 did not improve (15.97 percent) after the treatment.

3. Vitreous opacity: 34 patients age from 38 to 76 years old took F7 or its modifications for up to four weeks and 18 significantly improved (52.94 percent), 11 improved (32.35 percent) and five did not improve (14.70 percent).

4. Senile excessive tear syndrome: 22 patients age from 50 to 60 years old took F8 or its modification for an average of two weeks and 20 significantly improved (90.90 percent) and 2 improved (9.09 percent).

5. Prostate enlargement: 30 patients took F8 or its modification and 11 cured (36.66 percent), 13 improved (43.33 percent) and six did not improve (20 percent).

Toxicity and side effect: A very safe formula with no known side effect or toxicity.